211 related articles for article (PubMed ID: 1901401)
1. Ets1, when fused to the GAL4 DNA binding domain, efficiently enhances galactose promotor dependent gene expression in yeast.
Seneca S; Punyammalee B; Bailly M; Ghysdael J; Crabeel M
Oncogene; 1991 Mar; 6(3):357-60. PubMed ID: 1901401
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
[TBL] [Abstract][Full Text] [Related]
5. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
6. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation by human c-myb and v-myb genes.
Kalkbrenner F; Guehmann S; Moelling K
Oncogene; 1990 May; 5(5):657-61. PubMed ID: 2189102
[TBL] [Abstract][Full Text] [Related]
8. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
9. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
[TBL] [Abstract][Full Text] [Related]
10. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
11. Vectors allowing amplified expression of the Saccharomyces cerevisiae Gal3p-Gal80p-Gal4p transcription switch: applications to galactose-regulated high-level production of proteins.
Sil AK; Xin P; Hopper JE
Protein Expr Purif; 2000 Mar; 18(2):202-12. PubMed ID: 10686151
[TBL] [Abstract][Full Text] [Related]
12. SAGA is an essential in vivo target of the yeast acidic activator Gal4p.
Bhaumik SR; Green MR
Genes Dev; 2001 Aug; 15(15):1935-45. PubMed ID: 11485988
[TBL] [Abstract][Full Text] [Related]
13. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
Chen JH; Wright CD
Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
[TBL] [Abstract][Full Text] [Related]
14. Ets up-regulates MET transcription.
Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
[TBL] [Abstract][Full Text] [Related]
15. Activity of a C. elegans GATA transcription factor, ELT-1, expressed in yeast.
Shim YH; Bonner JJ; Blumenthal T
J Mol Biol; 1995 Nov; 253(5):665-76. PubMed ID: 7473742
[TBL] [Abstract][Full Text] [Related]
16. The Ets1 proto-oncogene is upregulated by retinoic acid: characterization of a functional retinoic acid response element in the Ets1 promoter.
Raouf A; Li V; Kola I; Watson DK; Seth A
Oncogene; 2000 Apr; 19(15):1969-74. PubMed ID: 10773887
[TBL] [Abstract][Full Text] [Related]
17. Overproduction of the Opi1 repressor inhibits transcriptional activation of structural genes required for phospholipid biosynthesis in the yeast Saccharomyces cerevisiae.
Wagner C; Blank M; Strohmann B; Schüller HJ
Yeast; 1999 Jul; 15(10A):843-54. PubMed ID: 10407264
[TBL] [Abstract][Full Text] [Related]
18. A novel GAL recombinant yeast strain for enhanced protein production.
Stagoj MN; Comino A; Komel R
Biomol Eng; 2006 Sep; 23(4):195-9. PubMed ID: 16707274
[TBL] [Abstract][Full Text] [Related]
19. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
20. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
